D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVGW
3651
DELISTED
Calavo Growers
CVGW
| $735K | ﹤0.01% |
23,147
-50,054
| -68% | -$2.01M |
|
3652
ITT
ITT
$17.8B
| $734K | ﹤0.01% |
11,229
-69,811
| -86% | -$5.09M |
|
3653
Grand Canyon Education
LOPE
$3.99B
| $733K | ﹤0.01% |
8,907
+427
| +5% | +$37K |
|
3654
Iron Mountain
IRM
$37.4B
| $732K | ﹤0.01% |
+16,648
| New | +$841K |
|
|
SA
3655
Seabridge Gold
SA
$2.69B
| $732K | ﹤0.01% |
61,607
-20,838
| -25% | -$264K |
|
3656
PUT
Logitech
LOGI
$16B
| $731K | ﹤0.01% |
+15,900
| New | +$836K |
|
3657
Crinetics Pharmaceuticals
CRNX
$8.88B
| $730K | ﹤0.01% |
37,155
+9,162
| +33% | +$187K |
|
|
HSKA
3658
PUT
DELISTED
Heska Corp
HSKA
| $729K | ﹤0.01% |
10,000
| – | – |
|
|
CMRC
3659
PUT
Commerce.com Inc Series 1
CMRC
$264M
| $728K | ﹤0.01% |
49,200
-10,000
| -17% | -$172K |
|
3660
N-able
NABL
$818M
| $726K | ﹤0.01% |
78,605
-127,228
| -62% | -$1.24M |
|
3661
PUT
Arista Networks
ANET
$214B
| $722K | ﹤0.01% |
25,600
+9,200
| +56% | +$265K |
|
3662
CALL
AGNC Investment
AGNC
$12.9B
| $720K | ﹤0.01% |
85,500
-128,500
| -60% | -$1.51M |
|
3663
CALL
Bloomin' Brands
BLMN
$736M
| $719K | ﹤0.01% |
+39,200
| New | +$779K |
|
3664
CALL
Tyson Foods
TSN
$21.5B
| $719K | ﹤0.01% |
+10,900
| New | +$862K |
|
3665
Castle Biosciences
CSTL
$725M
| $718K | ﹤0.01% |
+27,532
| New | +$772K |
|
3666
CALL
LendingTree
TREE
$572M
| $716K | ﹤0.01% |
30,000
+20,000
| +200% | +$780K |
|
|
XHR
3667
Xenia Hotels & Resorts
XHR
$2.01B
| $716K | ﹤0.01% |
51,932
-32,928
| -39% | -$525K |
|
3668
PUT
Digital Turbine
APPS
$1.02B
| $715K | ﹤0.01% |
49,600
-13,300
| -21% | -$254K |
|
3669
SkyWater Technology
SKYT
$1.53B
| $715K | ﹤0.01% |
+93,484
| New | +$1.1M |
|
3670
Agilon Health
AGL
$1.65B
| $713K | ﹤0.01% |
+1,217
| New | +$729K |
|
3671
Masco
MAS
$16.5B
| $712K | ﹤0.01% |
15,259
-104,232
| -87% | -$5.43M |
|
3672
CALL
Bread Financial
BFH
$4.36B
| $711K | ﹤0.01% |
22,600
+12,600
| +126% | +$494K |
|
3673
CorVel
CRVL
$3.14B
| $710K | ﹤0.01% |
15,381
-627
| -4% | -$32.5K |
|
3674
CytomX Therapeutics
CTMX
$701M
| $710K | ﹤0.01% |
489,630
+242,153
| +98% | +$373K |
|
3675
Itron
ITRI
$4.75B
| $708K | ﹤0.01% |
16,812
-23,192
| -58% | -$1.15M |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.